by | Apr 16, 2020 | Guilak, Farshid
— Technology Description
Researchers at Washington University in St. Louis have developed a method to create designer stem cells which provide a safer, more effective cell therapy approach to treating disease. Cell-based regenerative therapies could potentially be used to treat many diseases and res…
by | Apr 8, 2020 | Dougherty, Joseph
— Egr1Cre;Snap25Flp mice
by | Feb 21, 2020 | Ladenson, Jack
—
Antibody codes: 2B1.9 (3268) and 2F6.6
Publication: Bodor GS, Porter S, Landt Y, Ladenson JH. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 1992 Nov;38(11):2203-14.
Antibody codes: 5…
by | Feb 20, 2020 | Ladenson, Jack, Landt, Yvonne, Laterza, Omar, Modur, Vijay
— Technology Description
Researchers in Prof. Jack Ladenson’s laboratory have discovered biomarkers and associated antibodies for Alzheimer’s disease (AD) that could be used for early/presymptomatic diagnosis or in clinical trials for AD drugs.
This patented technology is based on the i…
by | Feb 20, 2020 | Dougherty, Joseph, Hoye, Mariah, Hyman, Theodore, Koval, Erica, Miller, Timothy
— Prof. Timothy Miller and colleagues have identified a motor neuron-specific, drug responsive microRNA (miR-218) that reflects the pathology of amyotrophic lateral sclerosis (ALS). This biomarker could be a target for therapeutic intervention or a proxy for motor neuron health and survival, including…